0
     

Report Added
Report already added
mRNA Vaccines & Therapeutics Market - Global Outlook and Forecast 2021-2027

mRNA Vaccines & Therapeutics Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of mRNA Vaccines & Therapeutics in Global, including the following market information:
Global mRNA Vaccines & Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global mRNA Vaccines & Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the mRNA Vaccines & Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Vaccines & Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global mRNA Vaccines & Therapeutics Market Segment Percentages, By Type, 2020 (%)
Infectious Disease Vaccines
Cancer Vaccines

China mRNA Vaccines & Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China mRNA Vaccines & Therapeutics Market Segment Percentages, By Application, 2020 (%)
Infectious Disease
Cancer

Global mRNA Vaccines & Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global mRNA Vaccines & Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total mRNA Vaccines & Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total mRNA Vaccines & Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccines & Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccines & Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccines & Therapeutics Overall Market Size
2.1 Global mRNA Vaccines & Therapeutics Market Size: 2021 VS 2027
2.2 Global mRNA Vaccines & Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top mRNA Vaccines & Therapeutics Players in Global Market
3.2 Top Global mRNA Vaccines & Therapeutics Companies Ranked by Revenue
3.3 Global mRNA Vaccines & Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 mRNA Vaccines & Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies mRNA Vaccines & Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Vaccines & Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 mRNA Vaccines & Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 mRNA Vaccines & Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Vaccines & Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Infectious Disease Vaccines
4.1.3 Cancer Vaccines
4.2 By Type - Global mRNA Vaccines & Therapeutics Revenue & Forecasts
4.2.1 By Type - Global mRNA Vaccines & Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global mRNA Vaccines & Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Vaccines & Therapeutics Market Size, 2021 & 2027
5.1.2 Infectious Disease
5.1.3 Cancer
5.2 By Application - Global mRNA Vaccines & Therapeutics Revenue & Forecasts
5.2.1 By Application - Global mRNA Vaccines & Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global mRNA Vaccines & Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global mRNA Vaccines & Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global mRNA Vaccines & Therapeutics Revenue & Forecasts
6.2.1 By Region - Global mRNA Vaccines & Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global mRNA Vaccines & Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America mRNA Vaccines & Therapeutics Revenue, 2016-2027
6.3.2 US mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.3.3 Canada mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.3.4 Mexico mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe mRNA Vaccines & Therapeutics Revenue, 2016-2027
6.4.2 Germany mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.4.3 France mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.4.4 U.K. mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.4.5 Italy mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.4.6 Russia mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.4.8 Benelux mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia mRNA Vaccines & Therapeutics Revenue, 2016-2027
6.5.2 China mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.5.3 Japan mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.5.4 South Korea mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.5.6 India mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America mRNA Vaccines & Therapeutics Revenue, 2016-2027
6.6.2 Brazil mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.6.3 Argentina mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa mRNA Vaccines & Therapeutics Revenue, 2016-2027
6.7.2 Turkey mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.7.3 Israel mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia mRNA Vaccines & Therapeutics Market Size, 2016-2027
6.7.5 UAE mRNA Vaccines & Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Corporate Summary
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Major Product Offerings
7.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue in Global (2016-2021)
7.1.5 Moderna Therapeutics Key News
7.2 CureVac
7.2.1 CureVac Corporate Summary
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Vaccines & Therapeutics Major Product Offerings
7.2.4 CureVac mRNA Vaccines & Therapeutics Revenue in Global (2016-2021)
7.2.5 CureVac Key News
7.3 Translate Bio
7.3.1 Translate Bio Corporate Summary
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Vaccines & Therapeutics Major Product Offerings
7.3.4 Translate Bio mRNA Vaccines & Therapeutics Revenue in Global (2016-2021)
7.3.5 Translate Bio Key News
7.4 BioNTech
7.4.1 BioNTech Corporate Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Vaccines & Therapeutics Major Product Offerings
7.4.4 BioNTech mRNA Vaccines & Therapeutics Revenue in Global (2016-2021)
7.4.5 BioNTech Key News
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Corporate Summary
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Major Product Offerings
7.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue in Global (2016-2021)
7.5.5 Sangamo Therapeutics Key News
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Corporate Summary
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Major Product Offerings
7.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Revenue in Global (2016-2021)
7.6.5 Argos Therapeutics Key News
7.7 In-Cell-Art
7.7.1 In-Cell-Art Corporate Summary
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Major Product Offerings
7.4.4 In-Cell-Art mRNA Vaccines & Therapeutics Revenue in Global (2016-2021)
7.7.5 In-Cell-Art Key News
7.8 eTheRNA
7.8.1 eTheRNA Corporate Summary
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Vaccines & Therapeutics Major Product Offerings
7.8.4 eTheRNA mRNA Vaccines & Therapeutics Revenue in Global (2016-2021)
7.8.5 eTheRNA Key News
7.9 Ethris
7.9.1 Ethris Corporate Summary
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Vaccines & Therapeutics Major Product Offerings
7.9.4 Ethris mRNA Vaccines & Therapeutics Revenue in Global (2016-2021)
7.9.5 Ethris Key News
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Corporate Summary
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Major Product Offerings
7.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue in Global (2016-2021)
7.10.5 Tiba Biotechnology Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. mRNA Vaccines & Therapeutics Market Opportunities & Trends in Global Market
Table 2. mRNA Vaccines & Therapeutics Market Drivers in Global Market
Table 3. mRNA Vaccines & Therapeutics Market Restraints in Global Market
Table 4. Key Players of mRNA Vaccines & Therapeutics in Global Market
Table 5. Top mRNA Vaccines & Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global mRNA Vaccines & Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global mRNA Vaccines & Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies mRNA Vaccines & Therapeutics Product Type
Table 9. List of Global Tier 1 mRNA Vaccines & Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Vaccines & Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - mRNA Vaccines & Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - mRNA Vaccines & Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - mRNA Vaccines & Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - mRNA Vaccines & Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global mRNA Vaccines & Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global mRNA Vaccines & Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Moderna Therapeutics Corporate Summary
Table 31. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offerings
Table 32. Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. CureVac Corporate Summary
Table 34. CureVac mRNA Vaccines & Therapeutics Product Offerings
Table 35. CureVac mRNA Vaccines & Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Translate Bio Corporate Summary
Table 37. Translate Bio mRNA Vaccines & Therapeutics Product Offerings
Table 38. Translate Bio mRNA Vaccines & Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. BioNTech Corporate Summary
Table 40. BioNTech mRNA Vaccines & Therapeutics Product Offerings
Table 41. BioNTech mRNA Vaccines & Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Sangamo Therapeutics Corporate Summary
Table 43. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offerings
Table 44. Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Argos Therapeutics Corporate Summary
Table 46. Argos Therapeutics mRNA Vaccines & Therapeutics Product Offerings
Table 47. Argos Therapeutics mRNA Vaccines & Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. In-Cell-Art Corporate Summary
Table 49. In-Cell-Art mRNA Vaccines & Therapeutics Product Offerings
Table 50. In-Cell-Art mRNA Vaccines & Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. eTheRNA Corporate Summary
Table 52. eTheRNA mRNA Vaccines & Therapeutics Product Offerings
Table 53. eTheRNA mRNA Vaccines & Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Ethris Corporate Summary
Table 55. Ethris mRNA Vaccines & Therapeutics Product Offerings
Table 56. Ethris mRNA Vaccines & Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Tiba Biotechnology Corporate Summary
Table 58. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offerings
Table 59. Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue (US$, Mn), (2016-2021)

List of Figures
Figure 1. mRNA Vaccines & Therapeutics Segment by Type
Figure 2. mRNA Vaccines & Therapeutics Segment by Application
Figure 3. Global mRNA Vaccines & Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global mRNA Vaccines & Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global mRNA Vaccines & Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by mRNA Vaccines & Therapeutics Revenue in 2020
Figure 8. By Type - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
Figure 12. US mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
Figure 24. China mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE mRNA Vaccines & Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. CureVac mRNA Vaccines & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Translate Bio mRNA Vaccines & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BioNTech mRNA Vaccines & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Argos Therapeutics mRNA Vaccines & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. In-Cell-Art mRNA Vaccines & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. eTheRNA mRNA Vaccines & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Ethris mRNA Vaccines & Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Report Title: mRNA Vaccines & Therapeutics Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW